113
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Case Files of the California Poison Control System, San Francisco Division: Blue Thunder Ingestion: Methanol, Nitromethane, and Elevated Creatinine

      research-article
      , ,
      Journal of Medical Toxicology
      Springer-Verlag
      Nitromethane, Methanol, Creatinine

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Case Presentation A 41-year-old man with a history of ethanol abuse was found on the streets with his clothing saturated with fecal material. In the emergency department (ED), he was confused and had an unsteady gait. He was sleepy and slow in responding, although easily arousable. He admitted to being depressed and said that he tried to commit suicide by consuming vodka and “Blue Thunder”, a fuel for radio-controlled racing cars that he had purchased from a hobby shop the day before presentation. He denied any other drug ingestion or previous medical history and was not taking any medications. He did not have any focal neurological symptoms, visual disturbance, gastrointestinal symptoms such as nausea or vomiting, or chest discomfort. His vital signs were within normal limits: temperature 36.4°C, blood pressure 145/87 mm Hg, heart rate 95/min, respiratory rate 16/min and pulse oximetry saturation 97% on room air. His physical examination was unremarkable except for an unsteady gait. His cranial nerves, motor, and sensory findings were grossly intact. As he had attempted to leave the ED several times despite being ataxic, he was placed in restraints and sedated with intravenous boluses of lorazepam and admitted for further workup. Computed tomography of his brain did not show any gross abnormalities. Initial laboratory data included: sodium 135 mmol/L, potassium 3.8 mmol/L, chloride 97 mmol/L, bicarbonate 21 mmol/L, blood urea nitrogen 7.9 mmol/L (22.0 mg/dL), creatinine 8,270 μmol/L (93.6 mg/dL), and glucose 6.5 mmol/L (117 mg/dL). The anion gap was 17 mmol/L. Lactic acid and hepatic enzymes were within normal limits. The serum ethanol, acetaminophen, and salicylate levels were below detection limits. Urinalysis was normal with a pH of 5.5. Serum samples were referred to an outside laboratory for methanol, ethylene glycol, acetone, isopropyl alcohol, and paraldehyde levels. After 4 h of supportive treatment including intravenous fluids, repeat laboratory results were: sodium 134 mmol/L, potassium 3.8 mmol/L, chloride 98 mmol/L, bicarbonate 23 mmol/L, blood urea nitrogen 6.9 mmol/L (19.0 mg/dL), and glucose 6.5 mmol/L (117 mg/dL). The laboratory had independently decided that nitromethane was an interfering substance and did not repeat the creatinine level. The anion gap was now 13 mmol/L and the calculated osmolality [1] was 282 mmol/kg. Serum osmolality determined by freezing point depression was 430 mmol/kg (reference range 275-295 mmol/kg). The osmolar gap was estimated to be 148 mmol/kg. Is this Patient’s Presentation Consistent with Methanol Poisoning? After ingestion, the hepatic enzyme alcohol dehydrogenase converts methanol to formaldehyde, which is then converted to formic acid by formaldehyde dehydrogenase [2]. Although formaldehyde is more toxic than formic acid, it does not accumulate during poisoning on account of its short half-life of about 1.5 min [3, 4]. Formic acid, an inhibitor of cytochrome oxidases c and aa3, primarily contributes to the toxic sequelae of methanol poisoning, including ocular toxicity and the fall in plasma bicarbonate concentration and consequent increase in anion gap [5]. Ocular toxicity essentially identical to that produced in methanol poisoning has been described after formate administration in animals [4]. Also, results suggest that formaldehyde is not a major factor in the toxic syndrome produced by methanol [6]. The clinical manifestations of methanol ingestion include headache, dizziness, nausea, vomiting, weakness, and epigastric pain, as well as developing an elevated anion gap acidosis. The severity of symptoms secondary to methanol poisoning appears to correlate with the degree of metabolic acidosis [7, 8]. Mortality correlates with the severity of acidosis and the formate concentration rather than with serum methanol concentration [9]. Although metabolic acidosis is a characteristic feature of methanol poisoning, its onset may be delayed for 18-24 h, or even longer (up to 72 h [10]) with concurrent ethanol ingestion [11–16], due to competition for the enzyme alcohol dehydrogenase. Thus, the patient may be relatively asymptomatic during the latent period [17]. Our patient had no measurable ethanol level, yet his acidosis was very mild with an anion gap of only 17 mmol/L and a bicarbonate level of 21 mmol/L. A significant anion gap may not be present early in the course of methanol intoxication. In a review of 113 acute methanol exposures reported to a poison center, metabolic acidosis was reported in only 26 cases (23%) [18]. Therefore, the absence of acidosis does not rule out methanol ingestion. Possible reasons for our patient not developing worsening or severe acidosis may include an inaccurate history of ingestion. He might have ingested only a small amount of methanol, or ingested it shortly before being found. He may also have co-ingested ethanol or other types of alcohols that are metabolized by alcohol dehydrogenase, such that the metabolism of methanol to formate was blocked. Such other alcohols might include ethylene glycol or isopropanol. However, ethanol was not detected and there was no nail polish remover-like odor detected in the patient, which would be present when isopropyl alcohol is metabolized to acetone. There was improvement in our patient’s anion-gap acidosis simply with hydration, which also argues against ethylene glycol and methanol ingestions. Thus, even though our patient currently appears relatively well, it is possible that he ingested methanol. It would be prudent to manage him as for methanol ingestion, given the history of ingestion and the very large osmolal gap. Nevertheless, it is unusual that our patient’s anion gap and acidosis improved in the short duration of supportive management with intravenous fluids alone. What is Nitromethane and What is its Toxicity? Nitromethane is a popular solvent in organic and electroanalytical chemistry [19]. It is also used as a fuel in racing, particularly drag racing, to enhance combustion [20]. The oxygen content of nitromethane enables it to burn with much less atmospheric oxygen in comparison to hydrocarbons such as gasoline. In model aircraft and remote-controlled car fuels such as “Blue Thunder”, the primary ingredient is generally methanol with some nitromethane (up to 65%, but rarely over 30% since nitromethane is expensive compared to methanol) and 10-20% lubricants (usually castor oil or a synthetic oil). During combustion, this fuel produces a characteristic blue smoke [20]. Nitromethane is highly lipid soluble, and acute exposures tend to be inadvertent dermal or ocular exposures which generally result in local irritation but no apparent sequelae [21]. The American Conference of Governmental Industrial Hygienists lists the adverse health effects of nitromethane as including dermal irritation, central nervous system depression, liver and thyroid toxicity, blood dyscrasias, and neuropathy [22]. Following acute inhalational exposure, animal studies suggest a relatively low toxicity of nitromethane [23, 24]. Rats and mice were exposed to nitromethane at a variety of concentrations for 6 h per day, 5 days per week, from 16 days to 2 years. In the 16-day study of rats, all those exposed to 1,500 ppm showed loss of coordination in the hindlimbs. Sciatic nerve degeneration was found in all rats exposed to 375 ppm and above. In the 13-week study, hindlimb paralysis was seen in all rats in the 1,500-ppm group. Rats exposed to 375 ppm of nitromethane or greater had minimal to mild degeneration of the spinal cord and sciatic nerve. In contrast, mice demonstrated no neurologic abnormalities in any of the studies [25]. Unfortunately, oral toxicity data in animals is limited. In a human case report, a 20-year-old woman who had worked for 2 years using a mixture of trichlorotrifluoroethane (94%), methanol (6%), and nitromethane (0.25%) developed Parkinsonism in the absence of other potential etiologies [26]. The authors concluded that exposure to nitromethane could have been the cause of the Parkinsonism. A 19-year-old man developed a primary, symmetric demyelinating polyneuropathy after a 2-month exposure to an industrial solvent composed primarily of 1-bromopropane, but also containing nitromethane and other components [27]. The authors attributed the neuropathy to the 1-bromopropane exposure. The limited acute toxicity of nitromethane suggests that exposures require only supportive care with no specific therapy [21]. Although different racing car fuels contain varying concentrations of nitromethane and methanol, management of this mixed poisoning should focus on the appropriate treatment for methanol toxicity. Why is There a False Elevation of Creatinine with Nitromethane? Nitromethane cause spurious elevations of the serum creatinine when the Jaffe colorimetric method is used to determine serum creatinine concentration [28–33]. This method involves injecting a sample of the patient’s serum into an alkaline picrate solution. Creatinine in the sample combines with alkaline picrate to form a red-colored complex or chromophore, the light absorbance of which can then be measured in the 470-550 nm range using a double-beam spectrophotometer. The rate of absorbance is directly proportional to the creatinine concentration in the serum [29]. Nitromethane also forms a red chromophore with alkaline picrate with an absorbance similar to that of the creatinine-picrate chromophore [30]. Thus, when nitromethane is present in a patient’s serum, the reaction of both creatinine and nitromethane with alkaline picrate can result in a significantly but spuriously elevated creatinine concentration [33]. Can the Degree of Cross-reactivity Predict the Nitromethane Level? There is a linear relationship between the concentration of nitromethane and the rise in serum creatinine concentration measured by the Jaffe method [21, 28]. This correlation could provide a surrogate marker for significant methanol exposure in those who ingest racing car fuel [32]. Analysis by least-squares linear regression of ten serum samples containing nitromethane showed the following relationship [29]: \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ {\hbox{Apparent}}\,\left[ {{\hbox{creatinine}},\,{{\hbox{mmol}} \mathord{\left/{\vphantom {{\hbox{mmol}} {\hbox{L}}}} \right.} {\hbox{L}}}} \right] = 0.99\left[ {{\hbox{nitromethane}},\,{{\hbox{mmol}} \mathord{\left/{\vphantom {{\hbox{mmol}} {\hbox{L}}}} \right.} {\hbox{L}}}} \right] + 0.21\left( {\pm 0.013} \right) $$\end{document} Using this equation in our patient, with a creatinine of 8,270 μmol/L (93.6 mg/dl), we estimated a nitromethane level of approximately 8 mmol/L: Apparent (creatinine, mmol/L) = 0.99 (nitromethane, mmol/L) + 0.21 (±0.013) 8.27 mmol/L = 0.99 (nitromethane, mmol/L) + 0.21 (±0.013) (Nitromethane) = (8.27-0.21(±0.013))/0.99 = 8.13-8.15 mmol/L A nitromethane level of 8 mmol/L would be expected to contribute only about eight to the osmol gap, leaving a residual, unexplained osmol gap of about 140. Assuming the remaining osmol gap is due to methanol alone, the estimated serum methanol level would be around 400 mg/dL, if multiplied by a conversion factor of 3.2 (one-tenth the molecular weight of methanol) [34]. The fatal oral dose of methanol is estimated to be 30-240 mL (20-150 g). The minimum toxic dose is approximately 100 mg/kg [35]. Serum methanol concentrations greater than 20 mg/dL (>6.24 mmol/L) are considered potentially toxic [36], and concentrations of greater than 40 mg/dL (>12.4 mmol/L) can be fatal, but individual sensitivity varies [37]. Based on these estimated levels, and without the benefit of a rapid analysis for methanol, it was decided that our patient had ingested a significant amount of methanol and he was initially treated with a loading dose of 15 mg/kg intravenous fomepizole and 2 hours of hemodialysis. Are There Other Causes of a Falsely Elevated Serum Creatinine Level? The concentration of creatinine in serum is the most widely used and commonly accepted measure of renal function in clinical medicine. In renal failure, deterioration of renal function, results in the accumulation of nitrogenous waste products, including creatinine [38]. In the absence of renal failure, elevated creatinine levels may be due to factors influencing creatine production as well as elimination. The total muscle mass is the most important determinant of the creatine pool size and thereby of creatinine production [39]. Hence serum creatinine is increased in people with increased muscle mass, those with a high-meat diet, users of anabolic steroids, and weight lifters [38]. Trauma or febrile states have been associated with significant increases in the excretion of creatinine [40–43]. Rhabdomyolysis or extensive crush injury may result in an increase of serum creatinine, at times exceeding what can be accounted for by the decrement in renal function [44], the excess creatinine is generally assumed to derive from injured muscle. But it was found that phosphocreatine was present in muscle in sufficient amounts to serve as a direct intermediate in the conversion of phosphocreatine to creatinine [45]. Other substances that can cause false elevations of the measured serum creatinine determined by the Jaffe method include ketoacids, acetone, pyruvate, glucose, uric acid, proteins, creatine, ascorbic acid, dopamine, and certain cephalosporins [46, 47]. High concentrations of bilirubin can falsely lower the serum creatinine concentration determined by the Jaffe method [46, 47]. Enzymatic methods for determining serum creatinine concentration are not affected by the presence of nitromethane in serum [21, 30, 47]. Substances that can interfere with this enzymatic method when present in the serum include creatine, bilirubin, dopamine, dobutamine, ascorbic acid, and calcium dobesilate [38, 46, 47]. What are Some Other Common Laboratory Analysis Cross-reactivities of Interest to Toxicologists? The techniques for detecting the presence of drugs include a variety of chromatographic methods, immunoassays, and chemical and spectrometric techniques. A number of interferences resulting in “false-positive” results have been reported [48]. Some common, important interferences resulting in false-positive results are listed in Table 1. Table 1 Examples of false-positive results in toxicology testing Drug Some reported cause(s) of a false positive result Amphetamines (urine) Cross-reacting stimulant drugs (MDMA, pseudoephedrine, etc.); cross-reacting non-stimulant drugs (bupropion, labetalol, ranitidine, sertraline, and trazodone); drugs metabolized to amphetamines (benzphetamine, selegiline) Ethylene glycol Other glycols; elevated triglycerides Lithium Use of a green-top Vacutainer specimen tube (contains lithium heparin, may raise Li level by 6-8 mEq/L) Methadone (urine) Diphenhydramine, verapamil Opiates (urine) May be triggered by ingestion of poppy seeds. Osmolality Use of a gray-top Vacutainer specimen tube (contains fluoride-oxalate) can raise measured osmolality by up to 150 mOsm/kg Phencyclidine (urine) Diphenhydramine, dextromethorphan, venlafaxine Tricyclic antidepressants Carbamazepine, cyclobenzaprine, quetiapine Adapted from Osterloh J and Haller CA, “Toxicology Testing,” in Poisoning and Drug Overdose, 5th edition, McGraw-Hill, 2007, pp. 43-44 Case Continuation Based on the history of ingestion of “Blue Thunder” fuel which may contain varying amounts of methanol (43-77%) and nitromethane (5-35%) and the presence of a large osmolal gap even after accounting for the contribution of the nitromethane, we recommended treatment with fomepizole, thiamine (the patient was suspected to be an alcoholic), folate, and transfer to a facility with dialysis capabilities. Two days later, the reference laboratory that the patient’s serum was sent out to reported the initial serum methanol concentration to be 399 mg/dL (124 mmol/L). The methanol concentration decreased to 47 mg/dL (1.47 mmol/L) approximately after completing 2 h after dialysis, while the apparent creatinine concentration decreased to 66.8 mg/dL. Ethylene glycol, acetone, isopropyl alcohol, acetaldehyde, and paraldehyde were not detected in the initial serum specimen. The patient continued to have daily dialysis (approximately 19 h of dialysis in total) until the osmolal gap narrowed and his apparent creatinine level was reduced to 168 μmol/L (1.9 mg/dL). He was also treated orally with folic acid 1 mg, thiamine 100 mg, and a multivitamin daily. Although the patient had no visual disturbances or any significant metabolic acidosis, he had auditory hallucinations thought to be related to alcohol withdrawal, which was treated with benzodiazepines. He was discharged to a psychiatric facility after 9 days of hospitalization. Conclusion Toy racing car and other nitromethane-containing fuel additives often contain significant concentrations of methanol. Unfortunately, most hospitals are not able to perform a rapid quantitative test for methanol. In addition, nitromethane causes a marked false elevation of the serum creatinine level when measured by the Jaffe method, which can be exploited to estimate the nitromethane level. If the relative concentrations of nitromethane and methanol in the fuel are known, then the estimated methanol level can be extrapolated. If the relative concentrations are not known, the nitromethane level can be subtracted from the osmolal gap to provide a residual estimate of the methanol level. Based on the extrapolated methanol level, appropriate treatment with fomepizole and hemodialysis can be recommended.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area.

          Arm muscle area (AMA, cm2) is currently calculated from triceps skinfold thickness (TSF, cm), and midarm circumference (MAC, cm). In assessing the accuracy of the current equation by comparison to AMA measured by computerized axial tomography, error in each of the four approximations made was found to result in a 20 to 25% overestimate of AMA. Two correctible error sources were: a 10 to 15% overestimation caused by assuming a circular midarm muscle compartment and a 5 to 10% overestimation due to inclusion of midarm cross-sectional bone area. Corrected AMA equations for men and women were respectively: [(MAC - pi x TSF)2/4 pi] - 10, and [MAC - pi x TSF)2/4 pip] - 6.5. With two additional study groups, the overall improved accuracy of the new equations was confirmed, although the average error for a given patient was 7 to 8%; the relationship between corrected AMA and total body muscle mass was established [muscle mass (kg) = (ht, cm2) (0.0264 + 0.0029 x corrected AMA)]; and the minimal range of corrected AMA values compatible with survival (9 to 11 cm2) was defined. Bedside estimates of undernutrition severity and prognosis can therefore be calculated from two simple measurements, TSF and MAC.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning.

            Almost all cases of acute methanol toxicity result from ingestion, though rarely cases of poisoning have followed inhalation or dermal absorption. The absorption of methanol following oral administration is rapid and peak methanol concentrations occur within 30-60minutes. Methanol has a relatively low toxicity and metabolism is responsible for the transformation of methanol to its toxic metabolites. Methanol is oxidized by alcohol dehydrogenase to formaldehyde. The oxidation of formaldehyde to formic acid is facilitated by formaldehyde dehydrogenase. Formic acid is converted by 10-formyl tetrahydrofolate synthetase to carbon dioxide and water. In cases of methanol poisoning, formic acid accumulates and there is a direct correlation between the formic acid concentration and increased morbidity and mortality. The acidosis observed in methanol poisoning appears to be caused directly or indirectly by formic acid production. Formic acid has also been shown to inhibit cytochrome oxidase and is the prime cause of ocular toxicity, though acidosis can increase toxicity further by enabling greater diffusion of formic acid into cells. Methanol poisoning typically induces nausea, vomiting, abdominal pain, and mild central nervous system depression. There is then a latent period lasting approximately 12-24 hours, depending, in part, on the methanol dose ingested, following which an uncompensated metabolic acidosis develops and visualfunction becomes impaired, ranging from blurred vision and altered visual fields to complete blindness. For the patient presenting with ophthalmologic abnormalities or significant acidosis, the acidosis should be corrected with intravenous sodium bicarbonate, the further generation of toxic metabolite should be blocked by the administration of fomepizole or ethanol and formic acid metabolism should be enhanced by the administration of intravenous folinic acid. Hemodialysis may also be required to correct severe metabolic abnormalities and to enhance methanol and formate elimination. For the methanol poisoned patient without evidence of clinical toxicity, the first priority is to inhibit methanol metabolism with intravenous ethanol orfomepizole. Although there are no clinical outcome data confirming the superiority of either of these antidotes over the other, there are significant disadvantages associated with ethanol. These include complex dosing, difficulties with maintaining therapeutic concentrations, the need for more comprehensive clinical and laboratory monitoring, and more adverse effects. Thus fomepizole is very attractive, however, it has a relatively high acquisition cost. The management of methanol poisoning includes standard supportive care, the correction of metabolic acidosis, the administration of folinic acid, the provision of an antidote to inhibit the metabolism of methanol to formate, and selective hemodialysis to correct severe metabolic abnormalities and to enhance methanol and formate elimination. Although both ethanol and fomepizole are effective, fomepizole is the preferred antidote for methanol poisoning.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fomepizole for the treatment of methanol poisoning.

              Methanol poisoning may result in metabolic acidosis, blindness, and death. The inhibition of alcohol dehydrogenase is fundamental to the treatment of methanol poisoning. We performed a multicenter study to evaluate fomepizole, an inhibitor of alcohol dehydrogenase, in the treatment of patients with methanol poisoning. We administered intravenous fomepizole to 11 consecutive patients who presented with methanol poisoning at a participating center. Serial clinical and laboratory studies, including measurements of plasma formic acid and fomepizole, were performed. The outcomes measured were the preservation of visual acuity, the resolution of metabolic acidosis, the inhibition of formic acid production, the achievment of therapeutic plasma concentrations of fomepizole with the dosing regimen, residual illness or disability, and death. Plasma formic acid concentrations were detectable in eight patients, and these concentrations were closely correlated with the initial arterial pH values (r=0.92, P<0.001). In response to fomepizole, plasma formic acid concentrations fell and metabolic abnormalities resolved in all patients. Nine patients survived. Seven patients initially had visual abnormalities, but at the end of the trial no surviving patient had any detectable visual deficits related to methanol poisoning. Fomepizole had few adverse effects. The two patients who died had anoxic brain injury that was present at the time of enrollment. During treatment, methanol had an elimination half-life of 54 hours. Fomepizole appears to be safe and effective in the treatment of methanol poisoning.
                Bookmark

                Author and article information

                Contributors
                angosy@gmail.com
                Journal
                J Med Toxicol
                Journal of Medical Toxicology
                Springer-Verlag (New York )
                1556-9039
                1937-6995
                30 March 2010
                30 March 2010
                March 2010
                : 6
                : 1
                : 67-71
                Affiliations
                California Poison Control System, San Francisco Division, University of California, 2789 25th Street, Suite 2022, San Francisco, CA 94110 USA
                Article
                42
                10.1007/s13181-010-0042-5
                2861177
                20352541
                f8ec9a32-44bb-4f0a-a485-c360e3e9b59e
                © The Author(s) 2010
                History
                Categories
                Toxicology Case Files
                Custom metadata
                © American College of Medical Toxicology 2010

                Toxicology
                methanol,creatinine,nitromethane
                Toxicology
                methanol, creatinine, nitromethane

                Comments

                Comment on this article